Iterum Therapeutics ITRMF
ITRMF
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Iterum Therapeutics plc (ITRMF) Payables (2017 - 2025)

Iterum Therapeutics (ITRMF) posted quarterly Payables of $577000.0 for Q3 2025, down 30.9% year-over-year from $835000.0 in Q3 2024, and down 51.47% quarter-over-quarter from $1.2 million in Q2 2025.

Iterum Therapeutics plc (ITRMF) Payables (2017 - 2025) Analysis & Trends

Iterum Therapeutics' Payables history runs 9 years deep, the most recent figure standing at $577000.0 for Q3 2025.

  • In Q3 2025, Payables fell 30.9% year-over-year to $577000.0; the TTM figure through Sep 2025 stood at $577000.0 (down 30.9% YoY), while the FY2024 annual figure was $251000.0, down 94.98% from the prior year.
  • Payables for Q3 2025 stood at $577000.0, down from $1.2 million in the prior quarter.
  • The five-year high for Payables was $30.7 million in Q1 2021, with the low at $251000.0 in Q4 2024.
  • The 5-year median for Payables is $3.0 million (2024), against an average of $5.6 million.
  • The sharpest annual moves came in 2023 and 2024: Payables surged 203.92% in 2023, then sank 94.98% in 2024.
  • Iterum Therapeutics' Payables stood at $6.9 million in 2021, then slumped by 57.18% to $3.0 million in 2022, then surged by 68.22% to $5.0 million in 2023, then tumbled by 94.98% to $251000.0 in 2024, then surged by 129.88% to $577000.0 in 2025.
  • Business Quant data shows ITRMF's Payables at $577000.0 in Q3 2025, $1.2 million in Q2 2025, and $413000.0 in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 577,000.00
Jun 30, 2025 1.19 Mn
Mar 31, 2025 413,000.00
Dec 31, 2024 251,000.00
Sep 30, 2024 835,000.00
Jun 30, 2024 822,000.00
Mar 31, 2024 2.97 Mn
Dec 31, 2023 5.00 Mn
Sep 30, 2023 5.59 Mn
Jun 30, 2023 3.87 Mn
Mar 31, 2023 2.42 Mn
Dec 31, 2022 2.97 Mn
Sep 30, 2022 1.84 Mn
Jun 30, 2022 2.41 Mn
Mar 31, 2022 5.14 Mn
Dec 31, 2021 6.94 Mn
Sep 30, 2021 9.46 Mn
Jun 30, 2021 23.81 Mn
Mar 31, 2021 30.72 Mn
Dec 31, 2020 29.68 Mn